---
figid: PMC7663714__ijms-21-08002-g002
figtitle: Interplay between different proangiogenic factors and their corresponding
  modulatory microRNAs
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC7663714
filename: ijms-21-08002-g002.jpg
figlink: pmc/articles/PMC7663714/figure/ijms-21-08002-f002/
number: F2
caption: The interplay between different proangiogenic factors and their corresponding
  modulatory microRNAs. VEGF-A, the chief proangiogenic entity, activates PI3K/Akt,
  ERK1/2 and JAK2/STAT3. Phosphorylated STAT3 leads to HIF-1α activation, which further
  increases VEGF-A levels through an autocrine loop. FGF2 activates PLC-γ1, uPA and
  FRS2. Downstream effectors of FRS2 include the MAPK pathway PI3K/Akt and STAT3.
  Both VEGF-A and FGF2 are capable of activating a number of MMPs, such as MMP-1,2,7,9,
  which degrade the ECM and promote angiogenesis. Another major player in angiogenesis
  is considered to be hypoxia, which exerts its molecular effects through HIF-1α,
  the hypoxic master regulator. HIF-1α promotes the expression of a number of proangiogenic
  factors—PlGF, PDGFB and VEGF-A.
papertitle: 'Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in
  Non-Small Cell Lung Cancer Therapy.'
reftext: Alexandru Tirpe, et al. Int J Mol Sci. 2020 Nov;21(21):8002.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9414244
figid_alias: PMC7663714__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7663714__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7663714__ijms-21-08002-g002.html
  '@type': Dataset
  description: The interplay between different proangiogenic factors and their corresponding
    modulatory microRNAs. VEGF-A, the chief proangiogenic entity, activates PI3K/Akt,
    ERK1/2 and JAK2/STAT3. Phosphorylated STAT3 leads to HIF-1α activation, which
    further increases VEGF-A levels through an autocrine loop. FGF2 activates PLC-γ1,
    uPA and FRS2. Downstream effectors of FRS2 include the MAPK pathway PI3K/Akt and
    STAT3. Both VEGF-A and FGF2 are capable of activating a number of MMPs, such as
    MMP-1,2,7,9, which degrade the ECM and promote angiogenesis. Another major player
    in angiogenesis is considered to be hypoxia, which exerts its molecular effects
    through HIF-1α, the hypoxic master regulator. HIF-1α promotes the expression of
    a number of proangiogenic factors—PlGF, PDGFB and VEGF-A.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Spaca6
  - Mir185
  - Mir29a
  - Mir15a
  - Mir145a
  - Mir126a
  - Mir206
  - Mir494
  - Mir23a
  - Vegfa
  - Mir497
  - Mir140
  - Fgf2
  - Mir155
  - Mir101a
  - Mir195a
  - Mir106a
  - Mir200b
  - Akt1
  - Pik3r1
  - Frs2
  - Mir182
  - Jak2
  - Mapk3
  - Mapk1
  - Plau
  - Prap1
  - Hif1a
  - Stat3
  - Pigf
  - Pgf
  - Pdgfb
  - Mir210
  - Mir204
  - Mir451a
  - Mir338
  - Mir21a
  - Mir106b
  - Mmp9
  - Mmp13
  - Mmp7
  - Mmp2
  - Mir29c
  - MIR125A
  - MIR185
  - MIR29A
  - MIR15A
  - MIR145
  - MIR126
  - MIR206
  - MIR494
  - MIR23A
  - VEGFA
  - MIR497
  - MIR140
  - FGF2
  - FGF13
  - MIR101-1
  - MIR101-2
  - MIR155
  - MIR195
  - MIR106A
  - MIR200B
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - FRS2
  - MIR182
  - JAK2
  - MAPK3
  - MAPK1
  - PLAU
  - PRAP1
  - HIF1A
  - STAT3
  - PIGF
  - PGF
  - PDGFB
  - MIR210
  - MIR204
  - MIR451A
  - MIR338
  - MIR21
  - MIR106B
  - MIR29B1
  - MMP9
  - MMP1
  - MMP7
  - MMP2
  - MIR29C
  - 'Y'
---
